CDSCO panel rejects Glenmark proposal for use of Nitric Oxide Nasal Spray for prevention of COVID 19
Citing lack of strong evidence on the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the drug major Glenmark's proposal for the additional indication of Nitric Oxide Nasal Spray.This came after the drug major Glenmark presented their proposal before...
Citing lack of strong evidence on the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the drug major Glenmark's proposal for the additional indication of Nitric Oxide Nasal Spray.
This came after the drug major Glenmark presented their proposal before the committee regarding the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection
For more details, check out the full story on the link below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd